BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26848032)

  • 21. B7-H3 and B7-H4 Expression in Breast Cancer and Their Association with Clinicopathological Variables and T Cell Infiltration.
    Kim NI; Park MH; Kweon SS; Lee JS
    Pathobiology; 2020; 87(3):179-192. PubMed ID: 32088722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between infiltration of FOXP3+ regulatory T cells and expression of B7-H1 in the tumor tissues of gastric cancer.
    Hou J; Yu Z; Xiang R; Li C; Wang L; Chen S; Li Q; Chen M; Wang L
    Exp Mol Pathol; 2014 Jun; 96(3):284-91. PubMed ID: 24657498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expressions of osteopontin and B7-H4 in epithelial ovarian neoplasm and their significance].
    Zhang LL; Shao SL; Wu Y
    Chin J Cancer; 2010 Jan; 29(1):25-9. PubMed ID: 20038306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer.
    Arigami T; Uenosono Y; Ishigami S; Hagihara T; Haraguchi N; Natsugoe S
    World J Surg; 2011 Sep; 35(9):2051-7. PubMed ID: 21748517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.
    Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M
    Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer.
    Shen L; Qian Y; Wu W; Weng T; Wang FXC; Hong B; Wu Z; Wang Q; Sang Y; Zhang H; Zhou X; Yao H
    Hum Pathol; 2017 Aug; 66():79-85. PubMed ID: 28600225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expression of B7-H3 and B7-H4 in human gallbladder carcinoma and their clinical implications.
    Liu CL; Zang XX; Huang H; Zhang H; Wang C; Kong YL; Zhang HY
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4466-4473. PubMed ID: 27874953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma.
    Xie N; Cai JB; Zhang L; Zhang PF; Shen YH; Yang X; Lu JC; Gao DM; Kang Q; Liu LX; Zhang C; Huang XY; Zou H; Zhang XY; Song ZJ; Sun HX; Fu BM; Ke AW; Shi GM
    Cell Death Dis; 2017 Dec; 8(12):3205. PubMed ID: 29235470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of B7-H4 expression in matched primary pancreatic cancer and liver metastases.
    Qian Y; Sang Y; Wang FX; Hong B; Wang Q; Zhou X; Weng T; Wu Z; Zheng M; Zhang H; Yao H
    Oncotarget; 2016 Nov; 7(44):72242-72249. PubMed ID: 27750217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B7-H4 expression is associated with tumor progression and prognosis in patients with osteosarcoma.
    Dong Q; Ma X
    Biomed Res Int; 2015; 2015():156432. PubMed ID: 25954746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-deficiency of B7-H3 and B7-H4 identifies high CD8 + T cell infiltration and better prognosis in pancreatic cancer.
    Si S; Wang L; Cao H; Xu Y; Zhan Q
    BMC Cancer; 2022 Feb; 22(1):211. PubMed ID: 35219310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential targeting of B7-H4 for the treatment of cancer.
    Podojil JR; Miller SD
    Immunol Rev; 2017 Mar; 276(1):40-51. PubMed ID: 28258701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and VISTA in craniopharyngioma.
    Wang Y; Deng J; Wang L; Zhou T; Yang J; Tian Z; Yang J; Chen H; Tang X; Zhao S; Zhou L; Tong A; Xu J
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32958683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate Cancer.
    Kreymborg K; Haak S; Murali R; Wei J; Waitz R; Gasteiger G; Savage PA; van den Brink MR; Allison JP
    Cancer Immunol Res; 2015 Aug; 3(8):849-54. PubMed ID: 26122284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial and tumor-associated endothelial expression of B7-H3 in cervical carcinoma: relation with CD8+ intraepithelial lymphocytes, FIGO stage, and phosphohistone H3 (PHH3) reactivity.
    Brustmann H; Igaz M; Eder C; Brunner A
    Int J Gynecol Pathol; 2015 Mar; 34(2):187-95. PubMed ID: 25675190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of increased B7 protein expression by infiltrating immune cells with progression of gastric carcinogenesis.
    Guo L; Liu Z; Zhang Y; Quan Q; Huang L; Xu Y; Cao L; Zhang X
    Medicine (Baltimore); 2019 Feb; 98(8):e14663. PubMed ID: 30813210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Could B7-H4 serve as a target to activate anti-cancer immunity?
    Wang L; Heng X; Lu Y; Cai Z; Yi Q; Che F
    Int Immunopharmacol; 2016 Sep; 38():97-103. PubMed ID: 27258187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
    Tan Z; Shen W
    Oncotarget; 2017 Apr; 8(16):27137-27144. PubMed ID: 28404927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B7-H4 expression is associated with cancer progression and predicts patient survival in human thyroid cancer.
    Zhu J; Chu BF; Yang YP; Zhang SL; Zhuang M; Lu WJ; Liu YB
    Asian Pac J Cancer Prev; 2013; 14(5):3011-5. PubMed ID: 23803071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of B7 family checkpoint proteins in cervical cancer.
    Zong L; Gu Y; Zhou Y; Kong Y; Mo S; Yu S; Xiang Y; Chen J
    Mod Pathol; 2022 Jun; 35(6):786-793. PubMed ID: 34848831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.